X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (131) 131
oncology (60) 60
human necessities (58) 58
chemistry (53) 53
metallurgy (53) 53
hematology (51) 51
immunology (44) 44
dendritic cells (40) 40
female (39) 39
immunotherapy (38) 38
male (38) 38
hygiene (36) 36
medical or veterinary science (36) 36
preparations for medical, dental, or toilet purposes (36) 36
cancer (35) 35
dendritic cells - immunology (35) 35
middle aged (34) 34
aged (32) 32
animals (29) 29
multiple-myeloma (29) 29
peptides (29) 29
beer (28) 28
biochemistry (28) 28
enzymology (28) 28
medicine, research & experimental (28) 28
microbiology (28) 28
mutation or genetic engineering (28) 28
organic chemistry (28) 28
spirits (28) 28
vinegar (28) 28
wine (28) 28
agriculture (27) 27
animal husbandry (27) 27
care of birds, fishes, insects (27) 27
fishing (27) 27
forestry (27) 27
hunting (27) 27
new breeds of animals (27) 27
rearing or breeding animals, not otherwise provided for (27) 27
trapping (27) 27
compositions thereof (26) 26
culture media (26) 26
microorganisms or enzymes (26) 26
myeloma (26) 26
propagating, preserving or maintaining microorganisms (26) 26
multiple myeloma (25) 25
abridged index medicus (24) 24
immunity (24) 24
neoplasms - immunology (24) 24
t-lymphocytes - immunology (24) 24
adult (23) 23
prognosis (20) 20
chemical and pharmacologic phenomena (19) 19
investigating or analysing materials by determining theirchemical or physical properties (19) 19
measuring (19) 19
physics (19) 19
testing (19) 19
mice (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (18) 18
treatment outcome (18) 18
bone-marrow (17) 17
compositions or test papers therefor (17) 17
condition-responsive control in microbiological orenzymological processes (17) 17
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (17) 17
measuring or testing processes involving enzymes, nucleicacids or microorganisms (17) 17
multiple myeloma - immunology (17) 17
multiple myeloma - pathology (17) 17
processes of preparing such compositions (17) 17
expression (16) 16
responses (16) 16
vaccination (16) 16
antigens (15) 15
lymphocytes (15) 15
multiple myeloma - drug therapy (14) 14
tumors (14) 14
apoptosis (13) 13
hemic and immune systems (13) 13
in-vivo (13) 13
neoplasms - therapy (13) 13
t-cells (13) 13
therapy (13) 13
antigens, neoplasm - immunology (12) 12
care and treatment (12) 12
health aspects (12) 12
survival rate (12) 12
cd8-positive t-lymphocytes - immunology (11) 11
dendritic cells - cytology (11) 11
killer cells, natural - immunology (11) 11
antigen (10) 10
antineoplastic agents - therapeutic use (10) 10
cells, cultured (10) 10
cross-presentation (10) 10
disease progression (10) 10
multidisciplinary sciences (10) 10
multiple myeloma - metabolism (10) 10
multiple myeloma - therapy (10) 10
t cells (10) 10
antibodies, monoclonal - therapeutic use (9) 9
cancer vaccines (9) 9
cells (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (355) 355
French (22) 22
German (10) 10
Spanish (3) 3
Chinese (2) 2
Danish (2) 2
Portuguese (2) 2
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Frontiers in immunology, ISSN 1664-3224, 2017, Volume 8
Journal Article
Cancer Research, ISSN 0008-5472, 2017, Volume 77, Issue 7, pp. 1510 - 1541
Cancer development is a complex process driven by inherited and acquired molecular and cellular alterations. Prevention is the holy grail of cancer... 
PLURIPOTENT STEM-CELLS | CIRCULATING TUMOR-CELLS | ONCOLOGY | BREAST-CANCER RISK | CLONAL HEMATOPOIESIS | B-CELL LYMPHOCYTOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | HOST-MICROBIOTA INTERACTIONS | NF-KAPPA-B | ESOPHAGEAL ADENOCARCINOMA | CARCINOMA IN-SITU | Precancerous Conditions - etiology | Genetic Predisposition to Disease | Genome-Wide Association Study | Neoplasms - etiology | Epigenesis, Genetic | Humans | Cellular Microenvironment | Neoplasms - prevention & control | Cancer Vaccines - immunology | Animals | DNA, Mitochondrial - genetics | Neoplasms - genetics | Neoplasms - immunology | Germ-Line Mutation | High-Throughput Nucleotide Sequencing | Mitochondria - physiology | Single-Cell Analysis | Precision Medicine | Eyelid | Animal models | Risk communication | Clinical trials | Biology | Ontogeny | Vaccines | Cell interactions | Immunity | Autophagy | Cancer vaccines | Prevention | Immunology | Uterus | Mathematical analysis | Hematopoiesis | Immunotherapy | Barrett's esophagus | Aging | Genetics | Mathematical models | Pancreas | Deoxyribonucleic acid--DNA | Immune system | Sequences | Immune response | BRCA1 protein | Cloning | Health risks | Environmental factors | Breast cancer | Pharmacology | Hemopoiesis | Esophagus | Communications systems | Chemotherapy | Biopsy | Computer applications | Skin | Metformin | Mutation | Environmental monitoring | Electron transport | Phagocytosis | Combinatorial analysis | Peritoneum | Cancer | BASIC BIOLOGICAL SCIENCES | Biological Science | 60 APPLIED LIFE SCIENCES | precision medicine | biology | cancer prevention | premalignancy | neoplasia
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 2/2017, Volume 198, Issue 3, pp. 1015 - 1021
Natural killer T (NKT) cells recognize lipid antigens presented by a class I MHC-like molecule CD1d, a member of the CD1 family. While most of the initial... 
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 1911 - 13
..., Madhav V. Dhodapkar1,3, David L. Jaye 3,5, Craig C. Hofmeister 1,3, Jonathan L. Kaufman 1,3, Vikas A. Gupta1,3, Daniel Auclair6, Jonathan J. Keats 7, Sagar Lonial1,3... 
SELECTIVE-INHIBITION | READ ALIGNMENT | BIOCONDUCTOR PACKAGE | MULTIDISCIPLINARY SCIENCES | DYSREGULATION | LENALIDOMIDE PLUS DEXAMETHASONE | CLASSIFICATION | MUTATIONS | CLASS DISCOVERY | GENETIC ABNORMALITIES | BREAKPOINTS | Recurrence | Translocation, Genetic | Prognosis | Multiple Myeloma - mortality | Humans | Gene Expression Regulation, Neoplastic | Antineoplastic Agents - therapeutic use | Genetic Loci | Myeloma Proteins - genetics | DNA Copy Number Variations | Plasma Cells - pathology | Ikaros Transcription Factor - genetics | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Immunoglobulin lambda-Chains - genetics | Multiple Myeloma - diagnosis | Proto-Oncogene Proteins c-myc - immunology | Drug Resistance, Neoplasm - immunology | Whole Genome Sequencing | Drug Resistance, Neoplasm - genetics | Enhancer Elements, Genetic | Lenalidomide - therapeutic use | Ikaros Transcription Factor - immunology | Survival Analysis | Protein Binding | Proto-Oncogene Proteins c-myc - genetics | Thalidomide - therapeutic use | Genome, Human | Multiple Myeloma - genetics | Immunologic Factors - therapeutic use | Plasma Cells - immunology | Translocation | Immunoglobulins | Multiple myeloma | Antibodies | Chains | Malignancy | Myc protein | Risk analysis | Loci | Enhancers | Chromosome translocations | Plasma cells | Health risk assessment
Journal Article
Journal Article